Assessment of sexual dysfunction in females with breast cancer after mastectomy in Upper Egypt | ||||
| Journal of Current Medical Research and Practice | ||||
| Volume 7, Issue 3, July 2022, Page 264-268 PDF (384.05 K) | ||||
| DOI: 10.4103/jcmrp.jcmrp_35_21 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
| Dalia Attallah; Hanan Morsy; Hesham Hamza; Hanaa Hamdy; Ahmed Hosny | ||||
| Abstract | ||||
| Objective To assess the sexual function among females suffering from breast cancer after mastectomy and to evaluate the effect of different cancer treatment modalities such as surgery, chemotherapy, and radiotherapy on the sexual function of these patients. Patients and methods One hundred females with cancer breast who had undergone mastectomy at childbearing age were recruited from the Outpatient Clinic of the Clinical Oncology Department in Assiut University Hospital and South Egypt Cancer Institute. Their sexual function was evaluated by the Arabic version of the Female Sexual Function Index (FSFI). Results There was a significant difference in desire, arousal, lubrication, orgasm, satisfaction, and full FSFI scores as they were significantly lower in participants who were on chemotherapy compared with those who were on radiotherapy. Sixty-five percent of participants had abnormal total FSFI scores. Conclusion Most participants who have undergone mastectomy experience sexual dysfunction after mastectomy. Chemotherapy has a negative impact on sexual function more than radiotherapy. | ||||
| Keywords | ||||
| Cancer breast; mastectomy; female sexual dysfunction | ||||
|
Statistics Article View: 32 PDF Download: 40 |
||||
